At a glance
- Originator Nonindustrial source
- Class Small molecules
- Mechanism of Action Adenosine triphosphatase inhibitors; Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Reperfusion injury
Most Recent Events
- 31 Jan 2001 Preclinical development for Reperfusion injury in Hungary (Unknown route)
- 31 Jan 2001 Preclinical development for Reperfusion injury in USA (Unknown route)